503 Views | 314 Downloads
Contact address: Sylvia M LaCourse, Department of Medicine, Division of Allergy and Infectious Diseases, University of Washington, 325 9th Avenue, Box 359931, Seattle, Washington, WA 98104, USA. sylvial2@u.washington.edu.
SL wrote the initial draft of the protocol.
LC developed the search strategy.
DH designed draft abstraction forms.
EO drafted the data analysis sections with input from SP and KRS.
KRS drafted the QUADAS-2 section.
KRS and SP contributed methodological advice.
All authors (EO, AB, DB, LC, DH, JM, SL, SM, KRS, and SP) provided input for the protocol.
We thank Vittoria Lutje, Cochrane Infectious Diseases Group (CIDG) Information Specialist, and Hannah Rogers, Emory University, for their assistance with developing the search strategy.
The review authors (EO, AB, DB, LC, DH, JM, SL, SM, KRS, SP) have no known conflicts of interest.
LC, DH, SL, JM, and SM have conducted primary research regarding evaluating symptom screening for TB in pregnant PLHIV.
Liverpool School of Tropical Medicine, UK.
Cystic Fibrosis Foundation (DH), USA.
NIH/NIAID K23 Career Development Award (SL, DH), USA.
NIH/NIAID R21 (DH), USA.
University of Washington Center for AIDS Research (SL, DH), USA.
University of Washington Strategic Analysis, Research & Training (START) Center (DB), USA.
US President’s Emergency Plan for AIDS Relief through the US Centers for Disease Control and Prevention (SM, SP), USA.
NIH/NIAID K23 (K23AI129854) Award (JM), USA.
NIH/NICHD R01 (R01HD081929) Award (JM), USA.
Department for International Development (DFID), UK.
The CIDG editorial base is supported by the Effective Health Care Research Consortium. This Consortium is funded by UK aid from the UK Government for the benefit of developing countries (Grant: 5242).
© 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.